Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology

Abstract Background This study was to investigate the effect and its possible mechanism of fucoidan on the development of spontaneous autoimmune diabetes in non-obese diabetic (NOD) mice. Methods 7-week-old NOD mice were randomly divided into three groups: control group, low-dose (300 mg/kg) and hig...

Full description

Bibliographic Details
Main Authors: Meilan Xue, Hui Liang, Xinqiang Ji, Ying Liu, Yinlin Ge, Lin Hou, Ting Sun
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Nutrition & Metabolism
Subjects:
Online Access:https://doi.org/10.1186/s12986-019-0392-1
_version_ 1819077541956157440
author Meilan Xue
Hui Liang
Xinqiang Ji
Ying Liu
Yinlin Ge
Lin Hou
Ting Sun
author_facet Meilan Xue
Hui Liang
Xinqiang Ji
Ying Liu
Yinlin Ge
Lin Hou
Ting Sun
author_sort Meilan Xue
collection DOAJ
description Abstract Background This study was to investigate the effect and its possible mechanism of fucoidan on the development of spontaneous autoimmune diabetes in non-obese diabetic (NOD) mice. Methods 7-week-old NOD mice were randomly divided into three groups: control group, low-dose (300 mg/kg) and high-dose (600 mg/kg) fucoidan-treatment groups. After 5 weeks of treatment, 10 mice per group were randomly selected to be sacrificed after feces collection. The remaining 12 mice per group were fed until 26 weeks of age to assess the incidence of diabetes. Results Treatment with fucoidan increased serum insulin level, delayed the onset and decreased the development of diabetes in NOD mice. Fucoidan reduced the levels of strong Th1 proinflammatory cytokines, but induced Th2-bias ed. cytokine response. And dentridic cells (DCs) in fucoidan treatment group were characterized as low expression of MHC class II and CD86 molecules. TLR4 expressions and the downstream molecules in pancreas were down-regulated in fucoidan-treated groups. There were significant differences in the composition of gut flora between NOD control group and fucoidan group. Lactobacillus and Akkermansia were significantly enriched in fucoidan group. Conclusions Fucoidan could prevent the development of autoimmune diabetes in NOD mice via regulating DC/Treg induced immune tolerance, improving gut microecology, down-regulating TLR4 signaling pathway, and maintaining pancreatic internal environment.
first_indexed 2024-12-21T18:58:51Z
format Article
id doaj.art-e14fff56ad0a42ec9ba4be3bc9b9cc75
institution Directory Open Access Journal
issn 1743-7075
language English
last_indexed 2024-12-21T18:58:51Z
publishDate 2019-12-01
publisher BMC
record_format Article
series Nutrition & Metabolism
spelling doaj.art-e14fff56ad0a42ec9ba4be3bc9b9cc752022-12-21T18:53:33ZengBMCNutrition & Metabolism1743-70752019-12-0116111510.1186/s12986-019-0392-1Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecologyMeilan Xue0Hui Liang1Xinqiang Ji2Ying Liu3Yinlin Ge4Lin Hou5Ting Sun6Department of Biochemistry and Molecular Biology, Basic Medical College, Qingdao University of MedicineThe Institute of Human Nutrition, Qingdao University of MedicineDepartment of Gynaecology, the Affiliated Hospital of Qingdao UniversityDepartment of Biochemistry and Molecular Biology, Basic Medical College, Qingdao University of MedicineDepartment of Biochemistry and Molecular Biology, Basic Medical College, Qingdao University of MedicineDepartment of Biochemistry and Molecular Biology, Basic Medical College, Qingdao University of MedicineDepartment of Biochemistry and Molecular Biology, Basic Medical College, Qingdao University of MedicineAbstract Background This study was to investigate the effect and its possible mechanism of fucoidan on the development of spontaneous autoimmune diabetes in non-obese diabetic (NOD) mice. Methods 7-week-old NOD mice were randomly divided into three groups: control group, low-dose (300 mg/kg) and high-dose (600 mg/kg) fucoidan-treatment groups. After 5 weeks of treatment, 10 mice per group were randomly selected to be sacrificed after feces collection. The remaining 12 mice per group were fed until 26 weeks of age to assess the incidence of diabetes. Results Treatment with fucoidan increased serum insulin level, delayed the onset and decreased the development of diabetes in NOD mice. Fucoidan reduced the levels of strong Th1 proinflammatory cytokines, but induced Th2-bias ed. cytokine response. And dentridic cells (DCs) in fucoidan treatment group were characterized as low expression of MHC class II and CD86 molecules. TLR4 expressions and the downstream molecules in pancreas were down-regulated in fucoidan-treated groups. There were significant differences in the composition of gut flora between NOD control group and fucoidan group. Lactobacillus and Akkermansia were significantly enriched in fucoidan group. Conclusions Fucoidan could prevent the development of autoimmune diabetes in NOD mice via regulating DC/Treg induced immune tolerance, improving gut microecology, down-regulating TLR4 signaling pathway, and maintaining pancreatic internal environment.https://doi.org/10.1186/s12986-019-0392-1Type 1 diabetesNon-obese diabetic miceFucoidanImmune toleranceGut microecology
spellingShingle Meilan Xue
Hui Liang
Xinqiang Ji
Ying Liu
Yinlin Ge
Lin Hou
Ting Sun
Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology
Nutrition & Metabolism
Type 1 diabetes
Non-obese diabetic mice
Fucoidan
Immune tolerance
Gut microecology
title Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology
title_full Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology
title_fullStr Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology
title_full_unstemmed Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology
title_short Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology
title_sort fucoidan prevent murine autoimmune diabetes via suppression tlr4 signaling pathways regulation dc treg induced immune tolerance and improving gut microecology
topic Type 1 diabetes
Non-obese diabetic mice
Fucoidan
Immune tolerance
Gut microecology
url https://doi.org/10.1186/s12986-019-0392-1
work_keys_str_mv AT meilanxue fucoidanpreventmurineautoimmunediabetesviasuppressiontlr4signalingpathwaysregulationdctreginducedimmunetoleranceandimprovinggutmicroecology
AT huiliang fucoidanpreventmurineautoimmunediabetesviasuppressiontlr4signalingpathwaysregulationdctreginducedimmunetoleranceandimprovinggutmicroecology
AT xinqiangji fucoidanpreventmurineautoimmunediabetesviasuppressiontlr4signalingpathwaysregulationdctreginducedimmunetoleranceandimprovinggutmicroecology
AT yingliu fucoidanpreventmurineautoimmunediabetesviasuppressiontlr4signalingpathwaysregulationdctreginducedimmunetoleranceandimprovinggutmicroecology
AT yinlinge fucoidanpreventmurineautoimmunediabetesviasuppressiontlr4signalingpathwaysregulationdctreginducedimmunetoleranceandimprovinggutmicroecology
AT linhou fucoidanpreventmurineautoimmunediabetesviasuppressiontlr4signalingpathwaysregulationdctreginducedimmunetoleranceandimprovinggutmicroecology
AT tingsun fucoidanpreventmurineautoimmunediabetesviasuppressiontlr4signalingpathwaysregulationdctreginducedimmunetoleranceandimprovinggutmicroecology